P&K Skin Research Center피엔케이피부임상연구센타
347740 · KOSDAQ · ₩347740 · 피엔케이피부임상연구센타
₩1,811▼ ₩4 (0.22%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩23B | ₩18B | ₩15B | ₩18B | ₩17B |
| Cost of sales | ₩12B | ₩9.4B | ₩7.6B | ₩6.8B | ₩6.2B |
| Gross profit | ₩11B | ₩8.5B | ₩7.2B | ₩11B | ₩11B |
| Operating income | ₩3.9B | ₩2.6B | ₩1.4B | ₩5.6B | ₩6.5B |
| Net income | ₩4.6B | ₩5.7B | ₩4.7B | ₩7.1B | ₩7.3B |
| Net income to shareholders | ₩4.7B | ₩5.8B | ₩4.7B | ₩7.1B | ₩7.3B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩87B | ₩82B | ₩77B | ₩75B | ₩67B |
| Current assets | ₩46B | ₩48B | ₩51B | ₩60B | ₩44B |
| Cash and equivalents | ₩4B | ₩6.5B | ₩9.8B | ₩5B | ₩1.5B |
| Total liabilities | ₩6B | ₩5.2B | ₩3.2B | ₩3.7B | ₩4B |
| Current liabilities | ₩5B | ₩4.7B | ₩2.6B | ₩3.1B | ₩3.1B |
| Total equity | ₩80B | ₩77B | ₩74B | ₩71B | ₩63B |
| Shareholders' equity | ₩81B | ₩77B | ₩74B | ₩71B | ₩63B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩6.7B | ₩9B | ₩5.5B | ₩7.5B | ₩7.7B |
| Capital spending | −₩1.5B | −₩622M | ₩1.5B | ₩1.2B | ₩2.8B |
| Free cash flow | ₩5.2B | ₩8.4B | ₩4B | ₩6.3B | ₩4.9B |
| Dividends paid | −₩977M | −₩715M | ₩872M | ₩893M | — |
Consolidated where available. Amounts in won.
Also known as: P&K Skin Research Center / 피엔케이피부임상연구센타 / 347740 / KRX:347740
Source: KRX statistical information